Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
-
WiSe 2022
-
SoSe 2022
-
WiSe 2021
-
SoSe 2021
-
WiSe 2020
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients : 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trialIn: Nephrology Dialysis Transplantation (NDT), Jg. 38, 2023, Nr. 4, S. 982 – 991DOI (Open Access)
-
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphomaIn: Annals of Hematology, Jg. 102, 2023, Nr. 12, S. 3445 – 3455DOI (Open Access)
-
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma : Results from the PETAL trialIn: Journal of Cancer Research and Clinical Oncology, Jg. 148, 2022, Nr. 10, S. 2611 – 2621DOI (Open Access)
-
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyIn: Endocrine, Jg. 75, 2022, Nr. 1, S. 293 – 302DOI (Open Access)
-
Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis—A Randomized Clinical TrialIn: Kidney International Reports, Jg. 6, 2021, Nr. 3, S. 594 – 604DOI (Open Access)
-
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations : Comparison of the Deauville 5-Point Scale and the ΔSUVmₐₓ MethodIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 1, S. 37 – 42DOI (Open Access)
-
Smoking cessation potential among newly diagnosed cancer patients : A population-based study of the ten most common cancers in Massachusetts, USA, 2008–2013In: Annals of Epidemiology, Jg. 56, 2021, S. 55 – 60.e11
-
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trialIn: Hematological Oncology, 2020DOI (Open Access)
-
CSF and blood Kallikrein-8 : A promising early biomarker for Alzheimer's diseaseIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 91, 2020, Nr. 1, S. 40 – 48DOI (Open Access)
-
Corrigendum to ‘Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial’ [Eur J Canc 124 (January 2020) 25–36] (European Journal of Cancer (2020) 124 (25–36), (S0959804919307555), (10.1016/j.ejca.2019.09.027))In: European Journal of Cancer (EJC), Jg. 136, 2020, S. 207 – 208
-
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma : Post-hoc analysis from the PETAL trialIn: European Journal of Cancer (EJC), Jg. 124, 2020, S. 25 – 36
-
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapyIn: Cancer Medicine, Jg. 99, 2020, Nr. 22, S. 8386 – 8396DOI, Online Volltext (Open Access)
-
Metabolic tumor volume, cancer cell fraction, and prognosis–the case of T-cell/histiocyte-rich large B-cell lymphomaIn: Leukemia and Lymphoma, Jg. 61, 2020, Nr. 6, S. 1372 – 1379
-
Score performance of SAPS 2 and SAPS 3 in combination with biomarkers IL-6, PCT or CRPIn: PLoS ONE, Jg. 15, 2020, Nr. 9, S. e0238587DOI (Open Access)
-
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determinationIn: Data in Brief, Jg. 28, 2020, 104976DOI (Open Access)
-
Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial : correlation with interim PET and outcomeIn: Blood Cancer Journal, Jg. 9, 2019, Nr. 9, S. 67DOI (Open Access)
-
Pharmacological properties of the novel nicotinamide modified release preparation nophos as complementary treatment option for hyperphosphatemia in hemodialysis petientsIn: Nephrology Dialysis Transplantation (NDT), Jg. 34, 2019, Nr. Suppl. 1, gfz103.SP604
-
Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trialIn: Trials, Jg. 20, 2019, Nr. 1, S. 99DOI, Online Volltext (Open Access)
-
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trialIn: Annals of Hematology, Jg. 98, 2019, Nr. 4, S. 897 – 907
-
The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center : A retrospective analysisIn: PLoS ONE, Jg. 14, 2019, Nr. 9DOI (Open Access)
-
Eculizumab in cold agglutinin disease (DECADE) : an open-label, prospective, bicentric, nonrandomized phase 2 trial.In: Blood Advances, Jg. 2, 2018, Nr. 19, S. 2543 – 2549DOI (Open Access)
-
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III TrialIn: Journal of Clinical Oncology (JCO), Jg. 36, 2018, Nr. 20, S. 2024 – 2034DOI (Open Access)
-
Reply to H.J.A adams et al and C. GisselbrechtIn: Journal of Clinical Oncology (JCO), Jg. 36, 2018, Nr. 32, S. 3273 – 3274
-
Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinomaIn: Clinical Transplantation, Jg. 31, 2017, Nr. 11, S. e13096
-
Phase II dose–response trials : A simulation study to compare analysis method performance under design considerationsIn: Journal of Biopharmaceutical Statistics, Jg. 27, 2017, Nr. 5, S. 885 – 901
-
Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting : A Randomized Clinical TrialIn: Stroke, Jg. 48, 2017, Nr. 10, S. 2769 – 2775DOI (Open Access)
-
Arthroscopic three-dimensional autologous chondrocyte transplantation using spheroids for the treatment of full-thickness cartilage defects of the hip jointIn: Knee Surgery, Sports Traumatology, Arthroscopy, Jg. 24, 2016, Nr. 6, S. 2032 – 2037
-
Is early treatment of cam-type femoroacetabular impingement the key to avoiding associated full thickness isolated chondral defects?In: Knee Surgery, Sports Traumatology, Arthroscopy, Jg. 24, 2016, Nr. 7, S. 2332 – 2337
-
Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive LymphomasIn: Blood, Jg. 126, 2015, Nr. 23
-
Positron Emission Tomography guided therapy of aggressive lympomas (PETAL) - the predictive value of quantitative PETIn: Journal of Nuclear Medicine (JNM), Jg. 56, 2015, Nr. Suppl. 3, S. 210
-
Outcome of aggressive lymphoma patients with a negative pretreatment positron emission tomography scanIn: Haematologica / The Hematology Journal, Jg. 99, 2014, Nr. Suppl. 1, 19th Congress of the European Hematology Association, Milan, Italy, June 12–15, 2014, S. 151(Open Access)
-
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)In: Blood, Jg. 124, 2014, Nr. 21, S. 391
-
Dynamic model for risk assessment in diffuse large B-cell lymphoma based on positron emission tomography scanning
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 67DOI (Open Access) -
Interim PET-Based Outcome Prediction in Diffuse Large B-Cell Lymphoma Patients Participating in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) Trial : Comparison of the Delta SUV Max Method and the Deauville 5-Point Scale
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, S. 1696 – 1696DOI (Open Access) -
Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL TrialIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4188 – 4188DOI (Open Access)
-
Diagnostic performance of 1,3-beta-D-glucan serum screening in patients after liver transplantationIn: Mycoses. Hoboken: Wiley-Blackwell - STM, Jg. 59, 2016, Nr. Suppl. 2, S. 20
-
Developing a prognostic risk score for patients with newly diagnosed aggressive Non-Hodgkin Lymphoma : clinical and statistical issuesDuisburg, Essen, 2019DOI, Online Volltext (Open Access)